HIGHLIGHTS
- who: Stefan K. Plontke from the Creighton University, United States have published the Article: Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear, in the Journal: (JOURNAL)
- what: The percentage of patients with profound hearing loss in this study showing a hearing gain > 40 dB was therefore slightly higher than seen in these previous RW catheter studies.
- how: The study is based on a retrospective chart review of patients treated for ISSHL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.